8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 9, 2020

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-35141	68-0370244
(Commission File Number)	(I.R.S. Employer Identification No.)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida	33401
(Address of Principal Executive Offices)	(Zip Code)

(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 7.01. Regulation FD Disclosure

On December 9, 2020, Rennova Health, Inc. (the “Company”) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Exhibit Description
99.1	Press Release dated December 9, 2020
99.2	Transcript of Interview of Seamus Lagan

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 10, 2020	RENNOVA HEALTH, INC.
	By:	/s/ Seamus Lagan
		Seamus Lagan
		Chief Executive Officer
		(principal executive officer)

3

EX-99.1

Exhibit 99.1

 

rennova health discusses BUSINESS UPDATE with the stock day podcast

WEST PALM BEACH, Fla. (December 9, 2020) – Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update.

Jolly began the interview by asking about the difficulties the rural healthcare industry is facing during the COVID-19 pandemic. Lagan explained that these difficulties include a reduction in revenue from scheduled visits and services, as well as increased costs associated with implementing visitor and staff safety, and acquiring protective equipment. “More recently, we’re seeing a lot more competition for staff, which is creating an additional strain on small hospitals,” said Lagan, adding that staff illness and the need for isolation is another difficulty for the rural healthcare community in the current pandemic.

“Have you made any changes to your business to help you survive these difficulties?” asked Jolly. “We’re always looking at ways to maintain and improve revenue,” said Lagan. “We’ve adopted a telehealth technology to support patients and staff when appropriate,” he continued. “We’ve invested in new equipment throughout the year at the facilities, particularly in diagnostic equipment that facilitates point of care testing for key tests in the emergency rooms,” he added. Lagan also shared that the Company has installed COVID testing equipment that provides a 15 minute turnaround time for results. “On top of the investments, we continue to build a very capable healthcare management team in our Knoxville office to oversee these facilities.”

“Do you expect any further financial assistance from the government or can you manage without it?” asked Jolly. “We sincerely hope that we will receive some additional financial assistance,” shared Lagan. “Like many others, we have applications submitted and are hopeful that our facilities qualify to receive some assistance very shortly,” said Lagan. “We’re in discussions for additional capital, but like many small facilities there is a current risk to an interruption of operations if some immediate assistance is not received.”

“Are you still confident in your business model?” asked Jolly. “The business model to operate small clusters of rural hospitals can definitely work. We’re starting to see advantages of a centralized management team and adoption of new technology and analytical tools to drive decision making,” explained Lagan. “We have to get through the current turmoil first, but we’re very confident that the long-term plan is solid,” he added.

Lagan then elaborated on the Company’s announcement regarding its agreement to separate its software and genetic diagnostics interpretation division into InnovaQor, Inc. “It will provide some additional opportunity to our shareholders. I’m really hoping that we have additional information available on this matter for shareholders in the coming days.”

To close the interview, Lagan expressed his confidence in the Company’s long-term goals as they continue to face the challenges of the pandemic. “We’re putting a management team in place that will be more than capable of growing this company to everything and more that we have anticipated,” said Lagan. “We’re still here and we still feel very confident that we can succeed in the long-term with our business.”

To hear Seamus Lagan’s entire interview, follow the link to the podcast here:

https://audioboom.com/posts/7747375-rennova-health-discusses-business-update-with-the-stock-day-podcast

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About Rennova Health, Inc.

Rennova operates three rural hospitals and a physician’s office in Tennessee and a physician’s office in Kentucky and provides industry-leading diagnostics and supportive software solutions to healthcare providers. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contacts:

Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com

EX-99.2

Exhibit 99.2

Rennova Health Interview

CEO Seamus Lagan on Uptick Newswire December 2020

Speakers: Everett Jolly and Seamus Lagan

Jolly: On today’s show, I’m bringing back a returning guest; it’s been months since the last time he has been on the show. We’re talking about none other than Rennova Health, Inc. They trade on the OTC markets under the ticker symbol ‘RNVA’, and with us today is the President and CEO of the company who is going to bring us up to speed, Mr. Seamus Lagan. Seamus, welcome back to the show.

Lagan: Thank you, Everett. It has been some time, so I appreciate the opportunity to get some additional information into the public domain.

Jolly: You know, the broader press has totally highlighted the difficulties faced by rural healthcare during this current pandemic. That being said, how is it affecting you guys and how are you moving forward?

Lagan: You know, Everett, everybody is being affected in some way; the rural hospitals definitely are seeing some difficulties. You can break them into four main categories, just to simplify it. First of all, there is a reduction in revenue – there are reduced patient visits and scheduling of services. Number two, you have increased costs associated with processes that you’re implementing to increase patient and visitor safety, and to acquire protective equipment to mitigate the spread of the virus. Number three, staff illness; this is probably more so in the last couple of months, increasing staff illness and the need to isolate after coming in contact with someone who has tested positive. And more recently, we’re seeing a lot more competition for staff, which is creating an additional strain on small hospitals.

Jolly: Let me ask you this, have you made any changes to your business to help you survive the difficulties that you just outlined?

Lagan: We’re always looking at ways to maintain and improve revenue. We’ve taken a number of steps throughout the year. We’ve adopted a telehealth technology to support patients and staff when appropriate. We’ve invested in new equipment throughout the year at the facilities, particularly in diagnostic equipment that facilitates point of care testing for key tests in the emergency rooms. That’s important because it enables a faster turnaround time for results, and also reduces the reliance of having the full clinical lab team available 24/7, and that’s a significant cost. A clinical lab is a significant cost in a small hospital; that’s a good move in the right direction. Look, we’ve previously announced that we’ve also installed COVID testing equipment that provides a 15-minute turnaround time for results, which is much better and much superior to the two to three days that most people experience for turnaround time. On top of the investments, we continue to build a very capable healthcare management team in our Knoxville office to oversee these facilities. In summary, we’ve adopted technology that improves patient care and decreases costs, and at the same time we’ve invested in a management team that will create significant savings by centralizing many of these functions that a small, stand-alone facility can’t sustain. So, that’s pretty much what we’re doing at the moment and have done throughout the year, Everett.

Jolly: As you know, Congress right now is in a meeting talking about a new stimulus package. That being said, do you expect any further financial assistance from the government or can you manage without it?

Lagan: We sincerely hope that we will receive some additional financial assistance. HHS, the body responsible for distributing stimulus assistance, is currently assessing or processing applications for additional stimulus that has been, as I understand, already provided by the government for healthcare. The last date for applications was November 6^th, so just over a month ago. Like many others, we have applications submitted and are hopeful that our facilities qualify and receive some assistance very shortly. Back to the second part of your question, we have plans and we’re in discussions for additional capital, but like many small facilities there is a current risk to an interruption of operations if some immediate assistance is not received, Everett. It is a difficult time and there’s no point in denying that.

Jolly: Well, you’ve definitely come a long way since you’ve been on the show for many years. That being said, give us a little bit of an outlook for Rennova of where we could from here. Are you still confident in your business model, and have you adopted any new venues that you may streamline that look more intriguing for you?

1

Lagan: Everett, the business model to operate small clusters of rural hospitals can definitely work. We’re starting to see advantages of a centralized management team and adoption of new technology and analytical tools to drive decision making. We have to get through the current turmoil first, but we’re very confident that the long-term plan is solid. You know, the need for rural healthcare is not going away, and while there needs to be a better collaboration of local authority payers and providers to improve a number of things that hinder these rural hospitals, we are confident that the future sustainability of these rural hospitals will be improved by operating a cluster of facilities in the same geographic location. That’s our model and our long-term plan. I think it’s also worthy to note that we’re at the finish line on the separation of the software business into InnovaQor, Inc. There’s some information already out there, but it’s taken a lot longer than we anticipated, but that will help Rennova as a company. It will provide some additional opportunity to our shareholders. I’m really hoping that we have additional information available on this matter for shareholders in the coming days, Everett. That’s how close we are.

Jolly: Seamus, I’m going to give you the last 20 seconds here. Through the interview and through the times you’ve been coming on the show, what is it that you want my listeners and your stockholders to take away from today’s interview?

Lagan: Well look, I think an understanding that this is a difficult time for all small businesses, particularly in healthcare, but we’ve continued to fight our way through the difficult times and we’re putting a management team in place that will be more than capable of growing this company to everything and more that we have anticipated. So, we’re still here and we still feel very confident that we can succeed in the long term with our business.

Jolly: The company that we’re highlighting today is Rennova Health, Inc. Look them up, you can find them on the OTC Markets under the ticker symbol ‘RNVA’. Seamus, I want to thank you for stopping by and coming on the show. If I don’t get to speak to you before the end of the year, happy holidays and Merry Christmas to you and your staff, and hopefully you’ll come back on the show in 40 or 50 days and give us an update.

Lagan: Thanks, Everett. I very much appreciate it.

2